In vitro Behaviour of Sesquiterpene Lactones and Sesquiterpene Lactone-Containing Plant Preparations in Human Blood, Plasma and Human Serum Albumin Solutions

Abstract

The interactions of the three sesquiterpene lactones (SLs) dihydrohelenalin acetate, dihydrohelenalin methacrylate and helenalin isobutyrate from Arnica montana and of parthenolide from Tanacetum parthenium as well as of three ethanolic Arnica preparations with human blood proteins using different matrices, human serum albumin (HSA), plasma and whole blood, were investigated. The extent of protein binding in human plasma or to human albumin differed significantly between individual SLs (dihydrohelenalin methacrylate < dihydrohelenalin acetate < helenalin isobutyrate << parthenolide), e. g., 30 % to 50 % of the SLs were bound to plasma. On the whole, SLs in the ethanolic preparations showed a lower degree of protein binding. Interestingly, although HSA has a reactive thiol group at its cysteine-34 position which is prone to react with the α,β-unsaturated carbonyl of SLs, our studies showed that less than 6 % of SLs are bound to this position within 60 minutes. Thus, a reaction with other amino acids as well as non-covalent interactions with plasma proteins have to be considered. Considering the biological activity of SLs in whole blood, our studies demonstrate that knowledge of their plasma protein binding is important for interpreting the reported data of in vitro and ex vivo assays.

Key words

Arnica montana - Tanacetum parthenium - Asteraceae - sesquiterpene lactone - protein binding - human serum albumin - plasma - whole blood - bioavailability

References

• 1 Schmidt T J. Toxic activities of sesquiterpene lactones: Structural and biochemical aspects.  Curr Org Chem. 1999;  3 577-608
• 2 Schmidt T J. Helenanolide-type sesquiterpene lactones - III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules.  Bioorg Med Chem. 1997;  5 645-53
• 3 Ruengeler P, Castro V, Mora G, Goren N, Vichnewski W, Pahl H L. et al . Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action.  Bioorg Med Chem. 1999;  7 2343-52
• 4 Humar M, García-Pineres A J, Castro V, Merfort I. Effect of sesquiterpene lactones on the expression of the activation marker CD69 and of IL-2 in T-lymphocytes in whole blood.  Biochem Pharmacol. 2003;  65 1551-63
• 5 Grippo A A, Wyrick S D, Lee K H, Shrewsbury R P, Hall I H. Disposition of an antineoplastic sesquiterpene lactone, [³ H]-plenolin, in BDF1 mice.  Planta Med. 1991;  57 309-14
• 6 Hill D W, Bailey E M, Camp B J. Tissue distribution and disposition of hymenoxon.  J Agric Food Chem. 1980;  28 1269-73
• 7 Knight D W. Feverfew: chemistry and biological activity.  Nat Prod Rep. 1995;  12 271-6
• 8 Fischer N H, Lu T, Cantrell C L, Castaneda-Acosta J, Quijano L, Franzblau S G. Antimycobacterial evaluation of germacranolides.  Phytochemistry. 1998;  49 559-64
• 9 Knuesel O, Weber M, Suter A. Arnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial.  Adv Ther. 2002;  19 209-18
• 10 Willuhn G. Arnica flowers: Pharmacology, toxicology and analytics of the sesquiterpene lactones - their main active substances. In: Lawson LD, Bauer R (editors) Phytomedicines of Europe. Washington: American Chemical Society 1996: p 118-32
• 11 Willuhn G, Leven W. On the qualitative and quantitative analysis of the sesquiterpene lactones of Arnicae flos DAB 9.  PZ (Pharmazeutische Zeitung) Wissenschaft. 1991;  136 32-9
• 12 Thomas L. Labor und Diagnose: Indikation und Bewertung von Laborbefunden für die Medizinische Diagnostik. 5 ed Frankfurt/Main; TH-Books 1998
• 13 Ellman G L. A colorimetric method for determining low concentrations of mercaptans.  Arch Biochem Biophys. 1958;  74 443-50
• 14 Peters T J r. Serum albumin.  Adv Protein Chem. 1985;  37 161-245
• 15 Kratz F, Warnecke A, Scheuermann K, Stockmar C, Schwab J, Lazar P. et al . Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound.  J Med Chem. 2002;  45 5523-33
• 16 Schmidt T J, Lyss G, Pahl H L, Merfort I. Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions.  Bioorg Med Chem. 1999;  7 2849-55
• 17 Hausen B M, Vieluf I K. Allergiepflanzen, Pflanzenallergene. Landsberg, München; Ecomed Verlagsgesellschaft 1997
• 18 Benard O, Balasubramanian K A. Effect of oxidant exposure on thiol status in the intestinal mucosa.  Biochem Pharmacol. 1993;  45 2011-5
• 19 Adamowicz A, Trafikowska U, Trafikowska A, Zachara B, Manitius J. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.  Med Sci Monit. 2002;  8 202-5
• 20 Heptinstall S, Groenewegen W A, Spangenberg P, Loesche W. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups.  J Pharm Pharmacol. 1987;  39 459-65
• 21 Franot C, Benezra C, Lepoittevin J P. Synthesis and interaction studies of ¹³C labeled lactone derivatives with a model protein using ¹³C NMR.  Bioorg Med Chem. 1993;  1 389-97